STAT+: FDA adcomm members’ ties to industry under scrutiny
New research found that nearly 40% of FDA advisory meetings held over a recent 20-year period included either a patient or consumer rep with active ties to an advocacy group…
Yesterday, a significant development emerged as Liquidia and United Therapeutics settled their ongoing patent litigation concerning Liquidia's treatment for pulmonary arterial hypertension. The two pharmaceutical giants have reached a settlement agreement to end their legal dispute. Meanwhile, researchers in Pittsburgh are embarking on an innovative trial to evaluate the impact of GLP-1s on social outcomes.
This groundbreaking study, organized by the Center for Addiction Science, Policy and Research (CASPR) in collaboration with the Allegheny County Department of Human Services, aims to enroll up to 1,200 adults with alcohol or opioid use disorder. These participants will also be at a high risk of criminal-justice involvement. Half of the participants will be randomly assigned to receive Novo Nordisk's Wegovy as part of the trial.
Written by urgent.news from STAT News's reporting — not their text. Machine-written — may contain errors; check the original before relying on it.
